This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1974 May;158(5):320-4.

doi: 10.1097/00005053-197405000-00002.

Deductive approaches to the catecholamine hypothesis of affective disorders

PMID: 4823932
DOI: 10.1097/00005053-197405000-00002

Deductive approaches to the catecholamine hypothesis of affective disorders

J R Wittenborn. J Nerv Ment Dis. 1974 May.

. 1974 May;158(5):320-4.

doi: 10.1097/00005053-197405000-00002.

Author

PMID: 4823932
DOI: 10.1097/00005053-197405000-00002

No abstract available

PubMed Disclaimer

Similar articles

Neuropsychopharmacology and the affective disorders. (Third of three parts).
Schildkraut JJ. Schildkraut JJ. N Engl J Med. 1969 Aug 7;281(6):302-8 concl. doi: 10.1056/NEJM196908072810606. N Engl J Med. 1969. PMID: 4894568 Review. No abstract available.
Biogenic amines and affective disorders.
Schildkraut JJ. Schildkraut JJ. Annu Rev Med. 1974;25(0):333-48. doi: 10.1146/annurev.me.25.020174.002001. Annu Rev Med. 1974. PMID: 4368455 Review. No abstract available.
Biogenic amine hypotheses of affective disorders.
Garver DL, Davis JM. Garver DL, et al. Life Sci. 1979 Jan 29;24(5):383-94. doi: 10.1016/0024-3205(79)90208-x. Life Sci. 1979. PMID: 372718 Review. No abstract available.
Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
Goodwin FK, Post RM. Goodwin FK, et al. Adv Biochem Psychopharmacol. 1974;11(0):341-55. Adv Biochem Psychopharmacol. 1974. PMID: 4276863 No abstract available.
Modified amine hypothesis for the aetiology of affective illness.
[No authors listed] [No authors listed] Lancet. 1972 Sep 16;2(7777):573-7. Lancet. 1972. PMID: 4115743 No abstract available.

See all similar articles

Cited by

Mood and behavior regulation: interaction of lithium and dopaminergic system.
Mohamadian M, Fallah H, Ghofrani-Jahromi Z, Rahimi-Danesh M, Shokouhi Qare Saadlou MS, Vaseghi S. Mohamadian M, et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Jul;396(7):1339-1359. doi: 10.1007/s00210-023-02437-1. Epub 2023 Feb 27. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36843130 Review.
Supra-second interval timing in bipolar disorder: examining the role of disorder sub-type, mood, and medication status.
Müller Ewald VA, Trapp NT, Sarrett ME, Pace BD, Wendt L, Richards JG, Gala IK, Miller JN, Wessel JR, Magnotta VA, Wemmie JA, Boes AD, Parker KL. Müller Ewald VA, et al. Res Sq [Preprint]. 2023 Jun 2:rs.3.rs-3006203. doi: 10.21203/rs.3.rs-3006203/v1. Res Sq. 2023. Update in: Int J Bipolar Disord. 2023 Oct 1;11(1):32. doi: 10.1186/s40345-023-00312-9. PMID: 37398216 Free PMC article. Updated. Preprint.
Supra-second interval timing in bipolar disorder: examining the role of disorder sub-type, mood, and medication status.
Ewald VAM, Trapp NT, Sarrett ME, Pace BD, Wendt L, Richards JG, Gala IK, Miller JN, Wessel JR, Magnotta VA, Wemmie JA, Boes AD, Parker KL. Ewald VAM, et al. Int J Bipolar Disord. 2023 Oct 1;11(1):32. doi: 10.1186/s40345-023-00312-9. Int J Bipolar Disord. 2023. PMID: 37779127 Free PMC article.
The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment.
Ashok AH, Marques TR, Jauhar S, Nour MM, Goodwin GM, Young AH, Howes OD. Ashok AH, et al. Mol Psychiatry. 2017 May;22(5):666-679. doi: 10.1038/mp.2017.16. Epub 2017 Mar 14. Mol Psychiatry. 2017. PMID: 28289283 Free PMC article. Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.